Antitumor activity of hu14.18-IL2 in patients with relapsed/refractory neuroblastoma: a Children's Oncology Group (COG) phase II study.
Shusterman
Suzanne
S
Dana-Farber Cancer Institute and Children's Hospital Boston, Boston, MA, USA.
London
Wendy B
WB
Gillies
Stephen D
SD
Hank
Jacquelyn A
JA
Voss
Stephan D
SD
Seeger
Robert C
RC
Reynolds
C Patrick
CP
Kimball
Jennifer
J
Albertini
Mark R
MR
Wagner
Barrett
B
Gan
Jacek
J
Eickhoff
Jens
J
DeSantes
Kenneth B
KB
Cohn
Susan L
SL
Hecht
Toby
T
Gadbaw
Brian
B
Reisfeld
Ralph A
RA
Maris
John M
JM
Sondel
Paul M
PM